| Notice Filed with SOS |
12/01/2016 |
| Rule |
ProposedRuleAttach2016-00628.pdf |
| Additional Information |
AddInfoAttach2016-00628.pdf |
| Statutory Authority |
Sections 12-42.5-101, 12-42.5-105, 12-42.5-603 and 24-4-103, C.R.S. |
| Description of Subjects/Issues |
The purpose of the addition of Board Rule 17.00.00 is to implement SB 16-135 which allows qualified Colorado-licensed pharmacists to perform evidence-based healthcare services pursuant to either: (1) an agreement and a protocol with Colorado-licensed physicians and Colorado-licensed advanced practice registered nurses; or (2) a statewide protocol. The purpose of the proposed repeal of Board Rule 18.00.00 is to achieve consistency within the Division of Professions and Occupations (“Division”) in that the duties of the Pharmacy Peer Health Assistance Program (“Program”) are governed under a single, shared business contract between the affected boards within the Division and the entity administering the Program. The purpose is to further eliminate unnecessary regulation. |
| Purpose/Objective of Rule |
The purpose of the addition of Board Rule 17.00.00 is to implement SB 16-135 which allows qualified Colorado-licensed pharmacists to perform evidence-based healthcare services pursuant to either: (1) an agreement and a protocol with Colorado-licensed physicians and Colorado-licensed advanced practice registered nurses; or (2) a statewide protocol.
The purpose of the proposed repeal of Board Rule 18.00.00 is to achieve consistency within the Division of Professions and Occupations (“Division”) in that the duties of the Pharmacy Peer Health Assistance Program (“Program”) are governed under a single, shared business contract between the affected boards within the Division and the entity administering the Program. The purpose is to further eliminate unnecessary regulation. |
| Comments |
The Board encourages interested parties to submit written comments to the letterhead address regarding any of the above-listed rulemaking matters no later than January 13, 2017. In addition, at the time and place designated in this notice, the Board of Pharmacy will afford interested parties an opportunity to submit written information, data, views or arguments. The Board also will afford interested parties an opportunity to make brief oral presentations unless the Board in its discretion determines that such oral presentations are unnecessary. All submissions will be considered. The rules under consideration may be changed or modified after public comment and hearing. |
| Submitted in response to issues raised by COLS/OLLS? |
No
|
| Is this rule adopted in response to recent legislation? |
Yes
|
| Recent legislation bill number |
SB 16-135
|
| Hearing Date |
01/19/2017 |
| Hearing Time |
09:30 AM |
| Hearing Location |
1560 Broadway Ste 110D, Denver Co 80202 |
| Contact Name |
Chris Gassen |
| Contact Title |
Pharmaceutical Inspector |
| Contact Telephone |
303-594-2562 |
| Contact email |
chris.gassen@state.co.us |